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Abstract
Background: The search for biomarkers of aging (BoAs) has been largely unsuccessful to-date and there is widespread
skepticism about the prospects of finding any that satisfy the criteria developed by the American Federation of Aging
Research. This may be because the criteria are too strict or because a composite measure might be more appropriate.
Telomere length has attracted a great deal of attention as a candidate BoA. We investigate whether it meets the criteria to
be considered as a single biomarker of aging, and whether it makes a useful contribution to a composite measure.
Methodology/Principal Findings: Using data from a large population based study, we show that telomere length is
associated with age, with several measures of physical and cognitive functioning that are related to normal aging, and with
three measures of overall health. In the majority of cases, telomere length adds predictive power to that of age, although it
was not nearly as good a predictor overall. We used principal components analysis to form two composites from the
measures of functioning, one including telomere length and the other not including it. These composite BoAs were better
predictors of the health outcomes than chronological age. There was little difference between the two composites.
Conclusions: Telomere length does not satisfy the strict criteria for a BoA, but does add predictive power to that of
chronological age. Equivocal results from previous studies might be due to lack of power or the choice of measures
examined together with a focus on single biomarkers. Composite biomarkers of aging have the potential to outperform age
and should be considered for future research in this area.
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Introduction
Increasing chronological age is associated with a greater
prevalence of a wide range of diseases, including most cancers,
renal disease, cardiovascular disease and neurodegenerative
conditions. At a subclinical level, increasing age is associated with
the decline of functional capacity in a number of seemingly
disparate areas, including: lung function, muscular strength,
arterial flexibility and cognitive ability. However, there is also a
great deal of variability between individuals of the same
chronological age which has been taken to imply that chronolog-
ical age is only an imprecise indicator of functional, or biological,
age. Others have cautioned against ascribing any causal role to age
per se [1]. These considerations have prompted the search for more
informative markers of aging, referred to as biomarkers of aging.
Baker and Sprott [2] defined a biomarker of aging (BoA) as ‘‘a
biological parameter of an organism that either alone or in some
multivariate composite will, in the absence of disease, better
predict functional capacity at some late age than will chronological
age’’. Despite proffering this definition, they did not believe it
likely that a biomarker would be found that satisfied the stronger
form of the definition, ie one that would alone be a better predictor
than chronological age. Their scepticism was later vindicated
when the American Federation for Aging Research concluded that
15 years of supported research on BoAs had failed to identify any
(see [3]). Johnson’s review of progress towards identifying BoAs
concluded ‘‘the general feeling of the aging community is that
biomarkers fulfilling all of the [National Institute on Aging] criteria
are unlikely to exist.’’
One biomarker that has attracted much attention as a suitable
candidate is telomere length. Telomeres are specialized nucleo-
protein complexes at the end of eukaryotic chromosomes. They
function to cap the chromosome, distinguishing the chromosome
end from DNA breaks and thus preventing chromosomal fusions.
Telomeres shorten during cell division due to the ‘end replication
problem’ [4,5]. This attrition can be mitigated in germ cells, stem
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cells and some blood cells via the action of the enzyme telomerase
but, because telomerase is essentially inactive in most somatic cells
[6,7], their telomeres are progressively shortened until exhaustion
triggers cell senescence. The rate of telomere attrition may also be
influenced by levels of oxidative stress [8]. Thus telomere length
not only has a clear rationale for being regarded as a BoA at the
cellular level, but it also has the potential to explain environmen-
tally induced differences in rates of ageing.
The case for telomere length as a BoA at the level of the human
organism was considered in a review by von Zglinicki and Martin-
Ruiz [9]. They found evidence of shorter telomeres in affected
tissues in several age-related conditions and diseases: immunose-
nescence, cardiovascular disease, sarcopenia, osteoporosis, osteo-
arthritis and skin aging. Moreover, there were plausible mecha-
nisms whereby telomere attrition might play a causal role. They
concluded that telomere length was a highly promising BoA, whilst
at the same time cautioning that it might simply be acting as a
proxy for long-term stress rather than a genuine cause.
Mather and colleagues [10] conducted a systematic review of
the epidemiological evidence relating telomere length to mortal-
ity/longevity and to measures that decline with ‘normal’ aging.
They found few mortality studies and those that they did find all
suffered from survivorship bias, whereby less healthy contempo-
raries of the study members have already died before telomere
length was ascertained. For associations of telomere length with
age related functional decline they found: two studies of lung
function, three of grip strength, five of cognitive function and
seven of blood pressure. The results for physical functioning were
equivocal although lack of statistical power was a serious problem.
Stronger support was observed for an association with cognitive
function but even there the results were ‘‘not unequivocal’’. One
additional study examined the relationship to self-rated general
health and found a significant association.
More recently, Bendix et al [11] studied 548 Danish twins aged
70+ and found an association with self-reported physical ability
(strength) but not cognitive function. In contrast, Harris et al [12]
studied 1,000 70 year old Scots and found no association with grip
strength or lung function but did find an association with cognitive
function amongst women.
In this study we provide further evidence from a large,
community based, sample – the West of Scotland Twenty-07
study. This study is the same order of magnitude as the two largest
studies identified in the review by Mather et al and has
comparable measures of physical and cognitive functioning,
namely: FEV1 as a measure of lung function; grip strength; pulse
pressure; four choice reaction time (CRT) and scores on part I of
the Alice Heim 4 (AH4) test of general mental ability [13]. We also
consider the association of telomere length to three measures of
general health, including the same measure of self-rated health
used by Njajou et al [14] in the study included in the review by
Mather et al.
We also evaluate telomere length against the alternative
criterion as part of a composite BoA. This approach requires
further elaboration in order to be operationalized. It implies that
candidate BoAs need to be identified separately but assessed
jointly.
A necessary condition for a BoA to be considered as part of a
composite measure might be that it is associated both with
chronological age and with one or more age-related measures of
functioning or health. The requirement that the measures of
functioning be ‘age-related’ implies that they too should be
associated with age. So for any given triad consisting of: a
candidate BoA, a measure of health or functioning and
chronological age, all three pairwise associations would need to
be statistically significant.
A sufficient condition for evaluation as part of a composite
might be that the biomarker adds explanatory power over and
above that of chronological age in the prediction of an age-related
measure of functioning or health. This condition would be satisfied
if the BoA has a significant association with functioning/health
after adjusting for age. If it does, then it clearly has the potential to
form part of a composite BoA that outperforms age. A weaker,
suggestive, condition would be that the biomarker shares some
predictive power with chronological age.
In short, the aim of this study is to augment the epidemiological
evidence for telomere length as a BoA with data from a relatively
large study, with several measures of health and functioning,
evaluating it both as a single BoA and as part of a composite BoA.
Methods
Sample
The West of Scotland Twenty-07 Study is a community-based
prospective cohort study of 4,510 individuals which was designed
to investigate the social processes that produce or maintain
inequalities in health and has been described in detail elsewhere
[15]. The study consists of three narrow age cohorts recruited at
the (approximate) ages of 16, 36 and 56 years in 1987/8 and
sampled on a further four occasions over a twenty year period.
Respondents who participated at baseline have been shown to be
representative of the general population of the sampled area [16].
Analyses are based on the data collected during the final interviews
in 2007/2008, when the respondents were aged approximately 36,
56 and 76 years. This was the only occasion on which blood was
collected. Data were collected by trained nurses in the homes of
the study participants and included blood sampling. Ethical
approval for each wave was obtained from the relevant local ethics
committee.
Telomere length
DNA was extracted from peripheral blood leukocytes using the
MaxwellH automated purification system according to the
manufacturer’s instructions (Promega, WI, USA). Telomere length
determination was performed blindly using a Roche Light Cycler
LC480. Briefly, telomere length analyses were performed in
triplicate for each sample, using a single-copy gene amplicon
primer set (acidic ribosomal phosphoprotein, 36B4) and a
telomere-specific amplicon primer set (27). This method deter-
mines the ratio of telomere repeat copy number to single copy
gene number (T/S) in experimental samples relative to a control
sample DNA. This normalized T/S ratio was used as the estimate
of relative telomere length (Relative T/S). Triplicates were
averaged prior to further analysis.
Physical Function
Measures of physical function were lung function, grip strength
and pulse pressure. Lung function was measured as the maximum
forced expiratory volume in 1 second (FEV1) from up to three
valid readings on a Micro Medical MS03 spirometer. Grip
strength was measured in kilograms using a JAMAR 5030J1 hand
dynamometer, and for analyses the mean of up to three readings
on the primary hand (highest reading hand if ambidextrous) was
used. Blood pressure was measured with an OMRON HEM-
705CP automated sphygmomanometer after the respondent had
been sitting at rest for 5 minutes. Pulse pressure (systolic –
diastolic) is used here.
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Cognitive Function
Two measures of cognitive function are included: Part I of the
Alice Heim 4 test of general mental ability [13] and four choice
reaction time. Four choice reaction time was measured with a
portable battery operated device originally designed for the UK
Health and Lifestyle Survey [17]. A description and diagram
showing its layout is given by Deary, Der & Ford [18]. The
measure used here is the mean choice reaction time of the correct
responses out of 40 trials.
General Health
The measures included here are self-rated health; the number of
chronic conditions reported by the participant in response to a
standard set of prompts and whether or not the participant is
registered disabled. Self-rated health has well documented
concurrent and prospective validity [19,20]. The number of
chronic conditions is an indicator for both general levels of
morbidity and co-morbidity while registered disability is an
indicator of poor physical functioning.
Statistical Analysis
Linear mixed models were used to relate telomere T/S ratio to
age and the measures of functioning in order to control for assay
variation by including a random effect of assay plate. Logistic and
Poisson mixed models were used for the binary health measures
and count of chronic conditions, respectively. Inverse probability
weights were used to correct for selective attrition. Principal
components analysis was used to form composite measures. To
compare the predictive power of age and the two principal
component scores, logistic and Poisson regression models were
used and the values of the Bayesian Information Criterion (BIC)
compared.
As blood was only collected on one occasion all analyses
presented here are cross-sectional and based on data from the fifth
wave of the Twenty-07 study. The analyses were conducted in
SAS version 9.2.
Results
Of the 2,604 study participants who took part at wave five:
2,568 had personal interviews (as opposed to proxy and postal
interviews); 2,310 consented to have telomere analysis performed
and blood was collected for 2,242. Sufficient blood was obtained
from 2,193 for DNA to be extracted and telomere length was
ascertained for 2,186. The mean intra-plate co-efficient of
variation for the telomere and 36B4 assays was 0.56% and
0.19% respectively. The amplification efficiency was 95% for both
telomere length and 36B4. Respective R2 values were .983 and
.994. One outlier was subsequently excluded. The working sample
comprised those 2,185 with valid measures of telomere length.
Table 1 gives descriptive statistics for the sample broken down
by sex and age cohort, labeled by approximate year of birth.
Telomere length and the measures of physical function, cognitive
function and health all deteriorate with increasing age (for pulse
pressure, reaction time, number of chronic conditions and
percentage registered disabled, a numerical increase is less
favourable). All of these associations with age, including that for
telomere length, are significant at p,.001 (see below). Men also
had shorter telomeres than women (p = .0246).
Thus, all the measures of health and functioning chosen were
significantly ‘age-related’ and, therefore, suitable for testing the
extent to which telomere length satisfies the criteria concerning the
prediction of functional aging.
Figure 1 shows the relationship of age to telomere length and to
the measures of physical and cognitive functioning. For the
purposes of comparison all measures have been standardized to
zero mean and unit standard deviation (z scores) and the sign has
been reversed for pulse pressure and choice reaction time (CRT)
so that lower scores on all variables are unfavourable. Here we see
that FEV1, pulse pressure and reaction time have the strongest,
and very similar, relationships to age. Those for AH4 and grip
strength are also very similar but somewhat weaker. Telomere
length is slightly weaker again.
Table 2 shows the results of regressing each of the measures of
functioning and health on telomere length and age. Results are
presented for models where telomere length and age are assessed
singly - the model contains either telomere length or age - and
where they are assessed jointly - the model contains both telomere
length and age. The final column shows the reduction in the
standardized regression coefficients due to mutual adjustment in
the joint model. All models are adjusted for sex and assay plate.
Telomere length is significantly associated with each of the
measures of health and functioning and in the expected direction:
Table 1. Descriptive information for the study by age cohort
and sex.
Mean (SD) N Women Men
1972 1952 1932 1972 1952 1932
Age 36.66 56.96 76.10 36.62 56.99 76.00
(0.41) (0.75) (0.63) (0.42) (0.93) (0.61)
414 468 310 361 398 234
Telomere T/S ratio 0.86 0.79 0.71 0.85 0.77 0.68
(0.20) (0.19) (0.18) (0.22) (0.18) (0.19)
414 468 310 361 398 234
FEV1 (L) 2.96 2.27 1.64 3.99 3.23 2.39
(0.46) (0.49) (0.43) (0.61) (0.63) (0.63)
408 462 296 353 384 223
Grip (Kg) 28.15 24.04 18.04 44.87 40.75 31.11
(5.8) (6.6) (6.1) (9.3) (8.9) (7.4)
394 426 279 343 378 216
Pulse Pressure (mm) 41.16 56.02 73.82 48.92 58.10 76.04
(8.4) (14.4) (18.9) (8.0) (12.5) (17.1)
413 466 304 360 398 234
Choice RT (ms) 540.15 635.14 789.61 533.37 634.04 784.05
(62.2) (91.1) (158.0) (67.8) (85.4) (134.3)
409 458 293 356 393 217
AH4 score 38.76 34.54 25.81 40.14 35.91 25.98
(9.8) (11.9) (11.0) (10.2) (11.4) (10.7)
402 448 265 355 377 206
Self-rated Health
(good)
75% 69% 53% 80% 74% 58%
413 466 310 359 397 233
N of chronic conditions 1.97 3.02 4.57 1.53 2.64 3.79
(1.6) (2.3) (2.3) (1.6) (2.0) (2.1)
413 466 310 359 398 233
Registered disabled 2% 8% 18% 3% 5% 18%
413 466 309 358 397 231
doi:10.1371/journal.pone.0045166.t001
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Figure 1. The relationship of telomere T/S ratio and measures of physical and cognitive functioning to age. Lines are fitted values from
simple linear regressions on age. All measures are standardized to zero mean and unit SD (z scores) and the sign is reversed for pulse pressure and
choice reaction time.
doi:10.1371/journal.pone.0045166.g001
Table 2. Results of regressing measures of functioning and health on telomere length and age.
Assessed Singly Assessed Jointly
Variable Estimate SE t p Estimate SE t p % reduction
(a) Telomere Length
FEV1 (L) 0.259 0.018 14.41 ,.001 0.031 0.013 2.28 0.023 88
Grip (Kg) 1.935 0.202 9.59 ,.001 0.247 0.187 1.32 0.188 87
Pulse Pressure (mm) 23.826 0.400 29.57 ,.001 0.772 0.323 2.39 0.017 120
Choice RT (ms) 248.02 3.315 214.48 ,.001 27.189 2.636 22.73 0.006 85
AH4 score 2.702 0.282 9.60 ,.001 0.760 0.279 2.73 0.006 72
Self-rated Health (good) 0.259 0.037 7.07 ,.001 0.145 0.039 3.73 ,.001 44
N chronic conditions 20.134 0.010 213.27 ,.001 20.019 0.011 21.75 0.079 86
Registered disabled 20.535 0.064 28.37 ,.001 20.244 0.068 23.57 ,.001 54
(b) Age
FEV1 (L) 20.571 0.012 248.11 ,.001 20.561 0.013 244.11 ,.001 2
Grip (Kg) 24.265 0.163 226.23 ,.001 24.182 0.174 223.99 ,.001 2
Pulse Pressure (mm) 11.076 0.283 39.19 ,.001 11.335 0.303 37.46 ,.001 22
Choice RT (ms) 102.96 2.233 46.11 ,.001 100.55 2.399 41.92 ,.001 2
AH4 score 25.426 0.245 222.17 ,.001 25.167 0.261 219.76 ,.001 5
Self-rated Health (good) 20.361 0.034 210.52 ,.001 20.314 0.036 28.62 ,.001 13
N chronic conditions 0.314 0.009 33.04 ,.001 0.307 0.010 30.33 ,.001 2
Registered disabled 0.921 0.066 14.02 ,.001 0.844 0.069 12.29 ,.001 8
Estimates are per SD of telomere T/S ratio or age.
Results weighted to the baseline sample.
All models include a random effect of telomere assay plate.
doi:10.1371/journal.pone.0045166.t002
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longer telomeres are associated with better health and functioning.
Telomere length, therefore, satisfies our necessary condition for a
BoA with respect to each of them.
Adjusting for age attenuates the effect estimate for telomere
length in every case with most coefficients being reduced by more
than 70%. However, the majority of them remain significant. Grip
strength and number of chronic conditions were attenuated to
non-significance and while pulse pressure has a significant effect in
the adjusted model, the effect there is in the opposite direction to
that expected. These results reveal two important points. First, the
marked attenuation after adjusting for age shows that the majority
of the variance predicted by telomere length is shared with age.
This is, of course, what would be expected of a BoA. Second, the
fact that telomere length remains a significant predictor after
adjusting for age in most cases shows that it adds predictive power
over and above age.
The results for age show that it is also significantly related to
each of the outcomes. This is simply confirmation that the
descriptive differences evident in table 1 are statistically significant.
Adjusting for telomere length hardly attenuates the effects at all
which shows that only a very small part of the age effect is
explained by telomere length.
For a BoA to satisfy the stronger criterion proposed by Baker &
Sprott it would need to account for a large part, if not all, of the
age effect. Clearly, telomere length falls short of achieving this.
Nonetheless, since it adds predictive power to that of age, it has the
potential to form part of a composite measure which would
outperform age as a predictor and would thus satisfy Baker &
Sprott’s second criterion as a BoA.
Since the measures of physical and cognitive functioning are
themselves also candidate BoAs they can be combined into a
composite measure with telomere length. It is generally considered
that a BoA should reflect ‘‘a basic process that underlies the aging
process, not the effects of disease’’ [10]. Consequently, it would be
inappropriate to include any of the three health measures.
One simple approach to forming a composite BoA is to take the
first unrotated principal component. Two such measures were
calculated: the first included the five measures of physical and
cognitive functioning and telomere length and the second included
the measures of functioning but omitted telomere length. The
proportions of the variance accounted for by these principal
components were 45% and 53%, respectively. Both principal
component scores correlated highly with age at r =2.75 and
2.74, respectively. (No importance should be attached to the sign
as this is essentially arbitrary.)
Table 3 shows the results of models using age and each of the
principal component scores to predict the health measures. For
each health measure three separate models are shown: one using
age and one each using the two principal component scores as
predictors. The Bayesian information criterion (BIC) is used to
assess the fit of the models with smaller values indicating better
fitting models. For each outcome, both principal component scores
produce a better fit than age. However, the very minor difference
between the fit of the two implies that telomere length makes only
a minor contribution to the overall performance of the composite.
Discussion
In this relatively large, population based, study telomere length
was related to sex, age and eight measures of health and
functioning. These comprised: three measures of physical func-
tioning (lung function, grip strength and pulse pressure); two
measures of cognitive functioning (four choice reaction time and a
general mental ability test score); and three measures of health
(self-rated health, registered disability, and the number of chronic
conditions). As all the measures of health and functioning were
themselves related to age, telomere length satisfies our necessary
condition for a candidate BoA with respect to all eight measures.
When adjusted for age, telomere length remained significant in
a majority of cases demonstrating that it adds predictive power
over and above age in five out of eight cases. On the other hand, it
only accounted for a very small proportion of the effect of age and
hence does not itself satisfy the stronger criterion of being by itself
a better predictor than age. This is, perhaps, unsurprising given
that two decades of research have not yet resulted in one candidate
BoA which does satisfy this criterion and many doubt whether one
will be found.
Even though they fall short of the stricter criterion for a BoA the
results here offer more support for telomere length as a candidate
BoA than the epidemiological evidence to date. There are a
number of reasons why this might be the case. First is the issue of
sample size and consequent statistical power to detect associations.
In the review of Mather et al only two studies had over 2,000
participants, one further study had around 1,000 (and Harris et al
[12], published subsequently, also had around 1,000) but the
remainder were smaller often considerably smaller. A second
reason is the measure(s) of functioning examined. Most studies
only examined a single measure – notable exceptions being those
of Harris [12,21] and Mather [22]. The most frequently studied
outcome, blood pressure, was the subject of two out of the three
largest studies but is one of the weaker associations in this study.
The largest study [23] examined cognitive function and did find a
significant association. A third issue is the age range covered. Most
of the studies had narrow age ranges and two involved birth
cohorts [12,21]. This range restriction will have weakened the
observed associations. It is possible that these studies would not
even have satisfied our necessary condition of having functional
measures that were significantly associated with age. Finally,
because of the emphasis on the stronger criterion of a BoA
whereby a single measure should outperform age, the studies
generally reported results that were adjusted for age. This
corresponds to our sufficient condition for consideration as part
of a composite BoA. Examining the association in birth cohorts
[12,21] is equivalent to adjusting for age. Taking all these
considerations together it is perhaps unsurprising that the evidence
to date has been equivocal.
Table 3. Results of models using age and principal
component scores to predict health outcomes.
Health Measure Effect Estimate SE t p BIC
Self-rated Health (good) Age 20.264 0.042 26.35 ,.0001 3750
PC1 0.631 0.045 13.95 ,.0001 3578
PC2 0.638 0.046 13.94 ,.0001 3579
Registered disabled Age 0.934 0.083 11.30 ,.0001 1449
PC1 21.182 0.084 214.14 ,.0001 1350
PC2 21.178 0.084 214.07 ,.0001 1355
N of Chronic Conditions Age 0.309 0.011 27.55 ,.0001 12635
PC1 20.319 0.011 229.17 ,.0001 12573
PC2 20.320 0.011 229.07 ,.0001 12583
PC1 includes telomere length; PC2 excludes it.
Based on N= 1867 with complete data for all measures.
doi:10.1371/journal.pone.0045166.t003
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At this point, it is worth mentioning a major limitation both to
this and previous studies, namely, the lack of longitudinal data on
telomere length. Longitudinal measures have the potential to
measure telomere loss more accurately than inter-individual
comparisons of telomere length and this may be a fruitful direction
for future research.
Nonetheless, in view of the results to-date and of the widespread
scepticism that a single BoA could be found we also evaluated
telomere length against the alternative criterion suggested by
Baker and Sprott as part of a composite BoA. All the measures of
physical and cognitive functioning included here change with
normal aging and have themselves been considered as candidate
BoAs. Hence they were included in the composites. Principal
components analysis was used to construct the composites as it is a
relatively simple approach which has the advantage of not relying
on any particular theory of measurement or on assumptions about
the structure of the underlying dimensions but can be regarded as
a simple rotation of the data. We produced two composites from
the functioning measures, one with and one without telomere,
length which we evaluated against chronological age in the
prediction of the health measures. Each produced a better fit than
age, although the contribution of telomere length was modest.
There is, however, a major caveat to the interpretation of this
result which relates to the purpose for which BoAs are sought,
specifically whether they are for the prediction or explanation of
biological aging. From the perspective of explaining biological
aging, the relatively modest contribution of telomere length to the
composite BoA here could be misleading as it operates at a lower
level than the other components, ie at the cellular level as opposed
to the systemic level. If, for example, telomere attrition was part of
the causal process generating age-related functional decline at the
higher level, then adjusting for those higher level measures of
functioning would underestimate its effect.
Where the aim is purely prediction, the results here suggest that
telomere length has relatively little to offer over and above the
other measures considered here. This may have important
practical and policy implications. As von Zglinicki recently noted
[24], telomere length tests are now available commercially and are
being actively marketed at the medical profession. Any physicians
contemplating this option would be well advised to consider some
of the functional measures examined here, such as grip strength,
FEV and reaction time. These are all simpler, cheaper (or even
free [25]) and have established predictive capacity.
Future research on BoAs should focus more on seeking out
composite markers rather than merely pitting candidates against
each other [26]. The methods used to do this will vary depending
on whether the aim is prediction or explanation and whether a
general purpose measure is sought or one optimized to a specific
outcome, such as age itself or some measure of health or
functioning. One class of statistical techniques suitable for
explanatory models are the so called structural equation models
within which composite measures are operationalized as latent
variables and may be simultaneously related to antecedents and/
or outcomes. Where the primary concern is with prediction,
machine learning methods might prove more fruitful. In either
case, the combination of biologically plausible biomarkers with
multivariate statistical methods offers an avenue for progress.
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